info@strategicmarketresearch.com
92, An Guha Lane, Arya Samaj Gali, Sambalpur, Odisha -768001
Indian Flag  IN: +91-826-083-6500
Home » therapeutics

therapeutics

Antisense and RNAi Therapeutics Market By Therapeutic Type (Antisense Oligonucleotides, RNA Interference); By Application (Genetic Disorders, Oncology, Neurodegenerative Diseases, Ophthalmology, Infectious Diseases); By Route of Administration (Intravenous, Subcutaneous, Intrathecal, Others); By End User (Biopharmaceutical Companies, Hospitals, Specialty Clinics, Research Institutes); By Geography, Segment Revenue Estimation, Forecast, 2024–2030

Introduction And Strategic Context

The Global Antisense And RNAi Therapeutics Market will witness a robust CAGR of 17.4% , valued at $5.8 billion in 2024 , expected t... Read More

Published Date: OCT-2025 | No Of Pages:196 | $ 4485

Acute Lymphocytic Lymphoblastic Leukemia Therapeutics Market Acute Lymphocytic (Lymphoblastic) Leukemia Therapeutics Market By Treatment Type (Chemotherapy, Targeted Therapy, Immunotherapy, Stem Cell Transplantation); By Route of Administration (Oral, Parenteral); By End User (Hospitals, Specialty Oncology Clinics, Academic & Research Institutes); By Geography, Segment Revenue Estimation, Forecast, 2024–2030.

Introduction And Strategic Context

The Global Acute Lymphocytic (Lymphoblastic) Leukemia Therapeutics Market will witness a robust CAGR of 8.7% , valued at $3.5 Read More

Published Date: OCT-2025 | No Of Pages:175 | $ 4485

Estrogen Receptor Positive (ER+) Breast Cancer Treatment Market By Drug Class (SERMs, Aromatase Inhibitors, SERDs, CDK4/6 Inhibitors, PI3K/AKT/mTOR Inhibitors, Others); By Line of Therapy (Adjuvant, Neoadjuvant, Metastatic/Advanced); By Route of Administration (Oral, Parenteral); By Distribution Channel (Hospital Pharmacies, Retail Pharmacies, Specialty Pharmacies); By Geography, Segment Revenue Estimation, Forecast, 2024–2030.

Introduction And Strategic Context

The Global Estrogen Receptor Positive (ER +) Breast Cancer Treatment Market will witness a robust CAGR of 6.5 % , ... Read More

Published Date: OCT-2025 | No Of Pages:192 | $ 4485

Artemisinin Combination Therapy Market By Drug Combination Type (Artemether-Lumefantrine, Artesunate-Amodiaquine, DHA-Piperaquine, Artesunate-Mefloquine, Others); By Route of Administration (Oral, Parenteral, Rectal Suppositories); By End User (Public Health Systems, Private Hospitals, NGOs, Pharmacies); By Geography, Segment Revenue Estimation, Forecast, 2024–2030.

Introduction And Strategic Context

The Global Artemisinin Combination Therapy Market will witness a robust CAGR of 6.8% , valued at $2.42 billion in 2024 , and is expected to appreciate and reach $3.6 billion ... Read More

Published Date: OCT-2025 | No Of Pages:178 | $ 4485

Periodontal Therapeutics Market By Product Type (Systemic Antibiotics, Local Antibiotic Delivery Agents, Anti-inflammatory Agents, Regenerative Therapeutics, Host Modulation Agents, Others); By Mode of Administration (Oral, Injectable, Topical); By End User (Dental Clinics, Hospitals, Academic & Research Institutions, Homecare Settings); By Geography, Segment Revenue Estimation, Forecast, 2024–2030.

Introduction And Strategic Context

The Global Periodontal Therapeutics Market will witness a robust CAGR of 6.5% , valued at $8.4 billion in 2024 , and is expected to appreciate and r... Read More

Published Date: OCT-2025 | No Of Pages:154 | $ 4485

Fabry Disease Treatment Market By Treatment Type (Enzyme Replacement Therapy, Pharmacological Chaperones, Gene Therapy, Substrate Reduction Therapy); By Route of Administration (Intravenous, Oral); By End User (Hospitals & Infusion Centers, Specialty Clinics & Genetic Centers, Home Healthcare); By Geography, Segment Revenue Estimation, Forecast, 2024–2030.

Introduction And Strategic Context

The Global Fabry Disease Treatment Market will witness a robust CAGR of 11.4% , valued at $2.15 billion in 2024, expected to apprec... Read More

Published Date: OCT-2025 | No Of Pages:182 | $ 4485

Cystic Fibrosis Therapeutics Market By Drug Type (CFTR Modulators, Antibiotics, Mucolytics, Others); By Route of Administration (Oral, Inhalation, Injectables); By End User (Hospitals, Pharmacies, Home Care, Research Institutions); By Region (North America, Europe, Asia Pacific, LAMEA), Segment Revenue Estimation, Forecast, 2024–2030.

Introduction And Strategic Context

The Global Cystic Fibrosis Therapeutics Market is positioned to grow at a robust CAGR of 8.5% , valued at $5.4 billion in 2024 , and is expected to ... Read More

Published Date: OCT-2025 | No Of Pages:169 | $ 4485

Irritable Bowel Syndrome Treatment Market By Product Type (Prescription Drugs, Over-the-Counter Drugs, Probiotics, Digital Therapeutics); By IBS Subtype (IBS-C, IBS-D, IBS-M, IBS-U); By Distribution Channel (Hospital Pharmacies, Retail Pharmacies, Online, Telehealth Platforms); By End User (Hospitals, Gastroenterology Clinics, ASCs, Self-care); By Geography, Segment Revenue Estimation, Forecast, 2024–2030.

Introduction And Strategic Context

The Global Irritable Bowel Syndrome (IBS) Treatment Market will witness a robust CAGR of 9.1% , valued at $3.84 billion in 2024 , expected to apprec... Read More

Published Date: OCT-2025 | No Of Pages:157 | $ 4485

Attention Deficit Hyperactivity Disorder (ADHD) Market By Drug Type (Stimulants, Non-Stimulants); By Demographic Group (Children and Adolescents, Adults); By Route of Administration (Oral, Transdermal, Others); By Distribution Channel (Retail Pharmacies, Hospital Pharmacies, Online Platforms); By Geography, Segment Revenue Estimation, Forecast, 2024–2030.

Introduction And Strategic Context

The Global Attention Deficit Hyperactivity Disorder (ADHD) Market will witness a robust CAGR of 7.5 %, valued at $19.4 billion in 2024Read More

Published Date: OCT-2025 | No Of Pages:159 | $ 4485

Primary Immunodeficiency Market By Disease Type (Antibody Deficiencies, Combined Immunodeficiencies, Phagocytic Cell Disorders, Complement Deficiencies, Others); By Treatment Type (Immunoglobulin Replacement Therapy, Targeted Biologics, Hematopoietic Stem Cell Transplantation, Gene Therapy, Supportive Therapies); By Route of Administration (Intravenous, Subcutaneous, Oral, Others); By End User (Hospitals & Specialty Clinics, Homecare Settings, Research & Academic Institutes, Others); By Geography, Segment Revenue Estimation, Forecast, 2024–2030.

Introduction And Strategic Context

The Global Primary Immunodeficiency Market is projected to witness a robust CAGR of 7.8% , valued at USD 8.9 billion in 2024, and expected to appreciate and reach Read More

Published Date: OCT-2025 | No Of Pages:193 | $ 4485

Thalassemia Market By Type (Alpha Thalassemia, Beta Thalassemia); By Treatment (Blood Transfusion, Iron Chelation Therapy, Gene Therapy, Bone Marrow/Stem Cell Transplantation, Others); By Route of Administration (Oral, Parenteral); By End User (Hospitals, Specialty Clinics, Research & Academic Institutes, Homecare Settings); By Geography, Segment Revenue Estimation, Forecast, 2024–2030

Introduction And Strategic Context

The Global Thalassemia Market will witness a steady CAGR of 8.5%, valued at $1.89 billion in 2024 , and is expected to expand and reach $Read More

Published Date: OCT-2025 | No Of Pages:189 | $ 4485

Pediatric Diabetes Therapeutics Market By Type (Type 1 Diabetes Mellitus, Type 2 Diabetes Mellitus); By Therapeutic Modality (Insulin Therapy, Oral Hypoglycemics, Adjunctive Therapies, CGM Systems, Insulin Delivery Devices); By Route of Administration (Injectable, Oral, Transdermal); By End User (Hospitals, Pediatric Specialty Clinics, Homecare Settings, Academic & Research Institutes); By Geography, Segment Revenue Estimation, Forecast, 2024–2030.

Introduction And Strategic Context

The Global Pediatric Diabetes Therapeutics Market will witness a robust CAGR of 8.5 % , valued at $12.6 billion in 2024Read More

Published Date: OCT-2025 | No Of Pages:197 | $ 4485

Enzyme Replacement Therapy Market By Product Type (Agalsidase Beta, Imiglucerase, Velaglucerase Alfa, Alglucosidase Alfa, Idursulfase, Others); By Indication (Gaucher Disease, Fabry Disease, Pompe Disease, Mucopolysaccharidoses, Others); By Route of Administration (Intravenous, Subcutaneous); By Geography, Segment Revenue Estimation, Forecast, 2024–2030.

Introduction And Strategic Context

The Global Enzyme Replacement Therapy (ERT) Market will witness a strong CAGR of 7.3%, valued at approximately $11.8 billion in 2024 , and is p... Read More

Published Date: OCT-2025 | No Of Pages:188 | $ 4485

Fungal Keratitis Treatment Market By Treatment Type (Topical Antifungal Therapy, Systemic Antifungal Therapy, Surgical Interventions, Adjunct Therapies); By Route of Administration (Topical, Oral, Intravenous, Ocular Injections); By End User (Hospitals, Specialty Eye Clinics, Academic and Research Institutes, Ambulatory Surgical Centers); By Geography, Segment Revenue Estimation, Forecast, 2024–2030

Introduction And Strategic Context

The Global Fungal Keratitis Treatment Market will witness a robust CAGR of 6.3 % , valued at USD 1.14 billion in 2024 , expected to appreciate and r... Read More

Published Date: OCT-2025 | No Of Pages:195 | $ 4485

Central Nervous System (CNS) Therapeutics Market By Drug Class (Small Molecule Drugs, Biologics and Advanced Therapies); By Indication (Neurodegenerative Diseases, Psychiatric Disorders, Epilepsy and Seizure Disorders, Multiple Sclerosis, Pain Management and Neuropathic Pain); By Route of Administration (Oral, Injectable, Transdermal/Others); By End User (Hospitals & Specialty Clinics, Retail & Online Pharmacies, Research & Academic Institutes, Mental Health Centers, Military & Veteran Health Systems); By Geography, Segment Revenue Estimation, Forecast, 2024–2030.

Introduction And Strategic Context

The Global Central Nervous System (CNS) Therapeutics Market will witness a robust CAGR of 8.6 % , valued at USD 138.2 billion in 2024Read More

Published Date: OCT-2025 | No Of Pages:164 | $ 4485

Idiopathic Pulmonary Fibrosis Treatment Market By Drug Type (Antifibrotic Agents, Corticosteroids, Immunosuppressants, Others); By Mechanism of Action (TGF-β Inhibition, Tyrosine Kinase Inhibition, Anti-inflammatory Modulation, Others); By Distribution Channel (Hospital Pharmacies, Retail Pharmacies, Online); By Geography, Segment Revenue Estimation, Forecast, 2024–2030.

Introduction And Strategic Context

The Global Idiopathic Pulmonary Fibrosis Treatment Market will witness a robust CAGR of 7.8% , valued at $3.1 billion in 2024 , expected to appreciate and reach $5.2 billion ... Read More

Published Date: OCT-2025 | No Of Pages:199 | $ 4485

Crohn’s Disease Therapeutics Market By Drug Class (Aminosalicylates, Corticosteroids, Immunomodulators, Biologics, Small Molecule Therapies, Others); By Route of Administration (Oral, Injectable, Intravenous); By Distribution Channel (Hospital Pharmacies, Retail Pharmacies, Online); By Geography, Segment Revenue Estimation, Forecast, 2024–2030.

Introduction And Strategic Context

The Global Crohn’s Disease Therapeutics Market will witness a robust CAGR of 6.8% , valued at $14.2 billion in 2024 , and is expected to appre... Read More

Published Date: OCT-2025 | No Of Pages:192 | $ 4485

Type 2 Diabetes Mellitus Treatment Market By Drug Class (Insulin Therapy, Oral Hypoglycemic Agents, GLP-1 Receptor Agonists, Dual Agonists); By Route of Administration (Oral, Injectable, Inhaled); By Distribution Channel (Hospital Pharmacies, Retail Pharmacies, Online); By Geography, Segment Revenue Estimation, Forecast, 2024–2030.

Introduction And Strategic Context

The Global Type 2 Diabetes Mellitus Treatment Market will witness a robust CAGR of 8.23 % , valued at approximately USD 58.5 billion in... Read More

Published Date: OCT-2025 | No Of Pages:184 | $ 4485

Urinary Incontinence Therapeutics Market By Drug Class (Anticholinergics, Beta-3 Adrenergic Agonists, Botulinum Toxin, Topical Estrogen Therapy, Others); By Disease Type (Stress Urinary Incontinence, Urge Urinary Incontinence/Overactive Bladder, Mixed Urinary Incontinence, Overflow Incontinence); By Route of Administration (Oral, Injectable, Topical); By Distribution Channel (Hospital Pharmacies, Retail Pharmacies & Drug Stores, Online Pharmacies); By Geography, Segment Revenue Estimation, Forecast, 2024–2030.

Introduction And Strategic Context

The Global Urinary Incontinence Therapeutics Market will witness a robust CAGR of 5.8% , valued at $4.01 billion in 2024 , and is expected to apprec... Read More

Published Date: OCT-2025 | No Of Pages:198 | $ 4485

Ankylosing Spondylitis Market By Drug Class (TNF Inhibitors, Interleukin Inhibitors, JAK Inhibitors, NSAIDs & Conventional DMARDs); By Route of Administration (Parenteral, Oral); By Distribution Channel (Hospital Pharmacies, Retail Pharmacies & Drug Stores, Online Pharmacies); By Geography, Segment Revenue Estimation, Forecast, 2024–2030.

Introduction And Strategic Context

The Global Ankylosing Spondylitis Market will witness a robust CAGR of 7.4% , valued at $6.9 billion in 2024, expected to appreciate and reach around $10.6 billion <... Read More

Published Date: OCT-2025 | No Of Pages:191 | $ 4485

Thyroid Gland Disorder Treatment Market By Treatment Type (Hormone Replacement Therapy, Antithyroid Medication, Radioactive Iodine Therapy, Surgery, Targeted Biologics); By Indication (Hypothyroidism, Hyperthyroidism, Thyroid Cancer, Other Disorders); By Distribution Channel (Hospital Pharmacies, Retail Pharmacies, Online Pharmacies); By Geography, Segment Revenue Estimation, Forecast, 2024–2030.

Introduction And Strategic Context

The Global Thyroid Gland Disorder Treatment Market will witness a robust CAGR of 6.4% , valued at approximately USD 3.9 billion in 2024 , expected to appreciate and reach USD... Read More

Published Date: OCT-2025 | No Of Pages:179 | $ 4485

Castrate-Resistant Prostate Cancer Market By Therapy Type (Hormonal Therapy, Chemotherapy, Immunotherapy, Radiopharmaceutical Therapy, Targeted Therapy); By Drug Class (Androgen Receptor Inhibitors, CYP17 Inhibitors, PARP Inhibitors, Cytotoxic Agents, Immune Checkpoint Inhibitors, Others); By Distribution Channel (Hospital Pharmacies, Retail Pharmacies, Online Pharmacies); By Geography, Segment Revenue Estimation, Forecast, 2024–2030

Introduction And Strategic Context

The Global Castrate-Resistant Prostate Cancer (CRPC) Market will witness a steady CAGR of 7.9% , valued at $10.2 billion in 2024 , expected to appre... Read More

Published Date: OCT-2025 | No Of Pages:160 | $ 4485

Anti-vascular Endothelial Growth Factor (Anti-VEGF) Therapeutics Market By Drug Type (Monoclonal Antibodies, Recombinant Fusion Proteins, Small Molecule Inhibitors, Biosimilars); By Route of Administration (Intravitreal Injection, Intravenous Infusion, Oral); By Application (Ophthalmology [AMD, DME, RVO], Oncology [Colorectal Cancer, NSCLC, RCC, Others]); By End User (Hospitals, Specialty Clinics, ASCs, Research Institutes); By Geography, Segment Revenue Estimation, Forecast, 2024–2030.

Introduction And Strategic Context

The Global Anti-Vascular Endothelial Growth Factor (Anti - VEGF) Therapeutics Market will witness a robust CAGR of 7.8%Read More

Published Date: OCT-2025 | No Of Pages:165 | $ 4485

Connective Tissue Disease Market By Disease Type (SLE, Systemic Sclerosis, Sjögren’s Syndrome, Polymyositis & Dermatomyositis, MCTD, Others); By Treatment Type (Immunosuppressants, Corticosteroids, NSAIDs, Biologics & Monoclonal Antibodies, DMARDs, Adjunctive Therapies); By Route of Administration (Oral, Intravenous, Subcutaneous, Topical); By End User (Hospitals, Specialty Clinics, Home Healthcare, Research Institutions); By Geography, Segment Revenue Estimation, Forecast, 2024–2030.

Introduction And Strategic Context

The Global Connective Tissue Disease Market will witness a robust CAGR of 7.3%, valued at $6.12 billion in 2024 , and is expected to appreciate and reach $9.34 bill... Read More

Published Date: OCT-2025 | No Of Pages:200 | $ 4485

Breast Adenocarcinoma Treatment Market By Therapy Type (Chemotherapy, Targeted Therapy, Hormonal Therapy, Immunotherapy, Others); By Route of Administration (Oral, Intravenous, Subcutaneous); By End User (Hospitals & Cancer Treatment Centers, Specialty Clinics, Ambulatory Surgical Centers, Homecare); By Geography (North America, Europe, Asia Pacific, Latin America, Middle East & Africa), Segment Revenue Estimation, Forecast, 2024–2030

Introduction And Strategic Context

The Global Breast Adenocarcinoma Treatment Market will witness a robust CAGR of 8.4% , valued at $12.7 billion in 2024 , expected to appreciate and reach $22... Read More

Published Date: OCT-2025 | No Of Pages:177 | $ 4485

Bipolar Disorder Treatment Market By Drug Class (Mood Stabilizers, Atypical Antipsychotics, Anticonvulsants, Antidepressants, Others); By Route of Administration (Oral, Parenteral, Transdermal); By End User (Hospitals, Outpatient Clinics, Private Practices, Online Pharmacies); By Geography, Segment Revenue Estimation, Forecast, 2024–2030.

Introduction And Strategic Context

The Global Bipolar Disorder Treatment Market will witness a robust CAGR of 6.8 % , valued at $7.4 billion in 2024 , expected to appreciate and reach $10.9 bi... Read More

Published Date: OCT-2025 | No Of Pages:182 | $ 4485

Lymphoma Treatment Market By Treatment Type (Chemotherapy, Immunotherapy, Targeted Therapy, Radiation Therapy, Stem Cell Transplantation); By Disease Type (Hodgkin Lymphoma, Non-Hodgkin Lymphoma); By Route of Administration (Oral, Intravenous, Subcutaneous); By End User (Hospitals, Specialty Cancer Centers, Academic and Research Institutes, Ambulatory Surgical Centers); By Geography, Segment Revenue Estimation, Forecast, 2024–2030

Introduction And Strategic Context

The Global Lymphoma Treatment Market will witness a robust CAGR of 9.3 % , valued at $12.4 billion in 2024 , and is expected to appreciate and reach... Read More

Published Date: OCT-2025 | No Of Pages:155 | $ 4485

Food Allergy Treatment Market By Treatment Type (Oral Immunotherapy, Epinephrine Auto-injectors, Biologics, Antihistamines); By Distribution Channel (Hospital Pharmacies, Retail Pharmacies, Online Platforms); By End User (Hospitals, Clinics, Allergy Specialty Centers, Homecare); By Geography, Segment Revenue Estimation, Forecast, 2024–2030.

Introduction And Strategic Context

The Global Food Allergy Treatment Market will witness a robust CAGR of 9.1% , valued at $2.41 billion in 2024 , expected to appreciate and reach $4.07 billion by 2030Read More

Published Date: OCT-2025 | No Of Pages:153 | $ 4485

Blastic Plasmacytoid Dendritic Cell Neoplasm Market By Treatment Type (Chemotherapy Regimens, Targeted Therapies, Immunotherapies); By Route of Administration (Intravenous, Subcutaneous); By End User (Hospitals and Oncology Centers, Specialty Clinics, Academic and Research Institutions); By Geography, Segment Revenue Estimation, Forecast, 2024–2030.

Introduction And Strategic Context

The Global Blastic Plasmacytoid Dendritic Cell Neoplasm ( BPDCN ) Market will witness a robust CAGR of 8.7% , valued at USD... Read More

Published Date: OCT-2025 | No Of Pages:153 | $ 4485

Hunter Syndrome Treatment Market By Treatment Type (Enzyme Replacement Therapy, Gene Therapy, Substrate Reduction Therapy, Supportive & Symptomatic Treatment); By Route of Administration (Intravenous, Intrathecal, Oral, Others); By End User (Hospitals, Specialty Clinics, Research Institutes, Homecare Settings); By Geography, Segment Revenue Estimation, Forecast, 2024–2030

Introduction And Strategic Context

The Global Hunter Syndrome Treatment Market will witness a robust CAGR of 7.4% , valued at $1.21 billion in 2024 , expected to appreciate and reach ... Read More

Published Date: OCT-2025 | No Of Pages:187 | $ 4485

Hepatitis Therapeutics Market By Drug Class (Direct-Acting Antivirals, Nucleos(t)ide Analogues, Immune Modulators, Combination Therapies); By Disease Type (Hepatitis B, Hepatitis C, Others); By Distribution Channel (Hospital Pharmacies, Retail Pharmacies, Online Pharmacies); By Geography, Segment Revenue Estimation, Forecast, 2024–2030

Introduction And Strategic Context

The Global Hepatitis Therapeutics Market will witness a robust CAGR of 6.8% valued at , $17.4 billion in 2024 , expected to appreciate and reach $25.9 billio... Read More

Published Date: OCT-2025 | No Of Pages:187 | $ 4485

Phenylketonuria (PKU) Treatment Market By Treatment Type (Medical Foods, Enzyme Replacement Therapy, Gene Therapy, Pharmacological Treatments); By Distribution Channel (Hospital Pharmacies, Retail Pharmacies, Online); By Region (North America, Europe, Asia Pacific, LAMEA), Segment Revenue Estimation, Forecast, 2024–2030

Introduction And Strategic Context

The Global Phenylketonuria ( PKU ) Treatment Market will witness a robust CAGR of 6.5% , valued at $1.2 bi... Read More

Published Date: OCT-2025 | No Of Pages:183 | $ 4485

Lysosomal Acid Lipase Deficiency Treatment Market By Therapy Type (Enzyme Replacement Therapy, Gene Therapy, Adjunctive Therapies); By Route of Administration (Intravenous, Oral, Subcutaneous); By End User (Specialty Clinics, Hospitals, Homecare Settings); By Geography, Segment Revenue Estimation, Forecast, 2024–2030.

Introduction And Strategic Context

The Global Lysosomal Acid Lipase Deficiency Treatment Market will witness a robust CAGR of 10.4% , valued at $425 million in 2024 , expected to appreciate and reach ... Read More

Published Date: OCT-2025 | No Of Pages:180 | $ 4485

Amyotrophic Lateral Sclerosis Treatment Market By Treatment Type (Medication-Based Therapy, Gene and Cell Therapy, Symptomatic Treatment); By Route of Administration (Oral, Intravenous, Subcutaneous, Others); By End User (Hospitals, Specialized Neurology Clinics, Homecare Settings, Research and Academic Institutes); By Geography, Segment Revenue Estimation, Forecast, 2024–2030.

Introduction And Strategic Context

The Global Amyotrophic Lateral Sclerosis ( ALS ) Treatment Market will witness a robust CAGR of 8.4% , valued at $1.26 billion in 2024 , expected to... Read More

Published Date: OCT-2025 | No Of Pages:150 | $ 4485

Autoimmune Hemolytic Anemia (AIHA) Treatment Market By Treatment Type (Corticosteroids, Immunosuppressants, Monoclonal Antibodies, Blood Transfusions, Surgical Interventions, Complement Inhibitors); By Route of Administration (Oral, Intravenous, Subcutaneous); By End User (Hospitals, Specialty Clinics, Ambulatory Surgical Centers, Research Institutions); By Geography, Segment Revenue Estimation, Forecast, 2024–2030.

Introduction And Strategic Context

The Global Autoimmune Hemolytic Anemia ( AIHA ) Treatment Market will witness a robust CAGR of 7.1% , valued at Read More

Published Date: OCT-2025 | No Of Pages:181 | $ 4485

Age-Related Macular Degeneration Market By Disease Type (Dry AMD, Wet AMD); By Drug Class (Anti-VEGF Agents, Complement Inhibitors, Gene Therapy, Others); By Route of Administration (Intravitreal, Oral, Subretinal, Others); By Distribution Channel (Hospital Pharmacies, Retail Pharmacies, Online); By Geography, Segment Revenue Estimation, Forecast, 2024–2030

Introduction And Strategic Context

The Global Age-Related Macular Degeneration ( AMD ) Market will witness a robust CAGR of 6.8% , valued at approximately $9.4 billion in 2024 , ... Read More

Published Date: OCT-2025 | No Of Pages:170 | $ 4485

Basal Cell Carcinoma (BCC) Treatment Market By Treatment Type (Surgical Procedures, Topical Medications, Targeted Therapies, Radiation Therapy, Immunotherapy); By Route of Administration (Topical, Oral, Intravenous); By End User (Hospitals, Dermatology Clinics, Ambulatory Surgical Centers, Home Healthcare); By Geography, Segment Revenue Estimation, Forecast, 2024–2030.

Introduction And Strategic Context

The Global Basal Cell Carcinoma ( BCC ) Treatment Market will witness a robust CAGR of 6.8% , valued at $6.4 billion in 2024 ,... Read More

Published Date: OCT-2025 | No Of Pages:151 | $ 4485

Metabolic Disorder Therapeutics Market By Product Type (Insulin and Insulin Analogs, Enzyme Replacement Therapies, Gene Therapies, RNA-Based Therapeutics, Small Molecule Drugs, Other Biologics); By Application (Diabetes Mellitus, Obesity, Lysosomal Storage Disorders, Hypercholesterolemia and Dyslipidemia, Other Metabolic Disorders); By End User (Hospitals, Specialty Clinics, Retail Pharmacies, Online Pharmacies, Research & Academic Institutions); By Geography, Segment Revenue Estimation, Forecast, 2024–2030.

Introduction And Strategic Context

The Global Metabolic Disorder Therapeutics Market will witness a robust CAGR of 7.4% , valued at USD 72.6 billion in 2024 , expected to appreciate and reach USD 112.5 billion... Read More

Published Date: OCT-2025 | No Of Pages:156 | $ 4485

Allergy Immunotherapy Market By Treatment Type (Subcutaneous Immunotherapy, Sublingual Immunotherapy); By Allergy Type (Allergic Rhinitis, Asthma, Venom Allergy, Food Allergy, Others); By Route of Administration (Oral, Injectable); By Distribution Channel (Hospital Pharmacies, Retail Pharmacies, Online, Specialty Clinics); By Geography, Segment Revenue Estimation, Forecast, 2024–2030.

Introduction And Strategic Context

The Global Allergy Immunotherapy Market will witness a robust CAGR of 11.3 % , valued at $2.49 billion in 2024 , and is expected to appreciate and r... Read More

Published Date: OCT-2025 | No Of Pages:154 | $ 4485

Osteoarthritis Therapeutics Market By Drug Class (NSAIDs, Corticosteroids, Viscosupplements, Biologics, DMOADs); By Route of Administration (Oral, Topical, Injectable); By Distribution Channel (Hospital Pharmacies, Retail Pharmacies, Online Pharmacies); By Geography, Segment Revenue Estimation, Forecast, 2024–2030

Introduction And Strategic Context

The Global Osteoarthritis Therapeutics Market is projected to grow at a robust CAGR of 9.3 % , reaching an estimated value of $ 16.42Read More

Published Date: OCT-2025 | No Of Pages:153 | $ 4485

Non-Alcoholic Steatohepatitis (NASH) Treatment Market By Drug Type (Vitamin E & Pioglitazone, Obeticholic Acid, Elafibranor, Selonsertib, Other Pipeline Molecules); By Mechanism of Action (Anti-fibrotic Agents, Anti-inflammatory Agents, Metabolic Modulators); By Route of Administration (Oral, Parenteral); By End User (Hospitals, Specialty Clinics, Academic & Research Institutes); By Geography, Segment Revenue Estimation, Forecast, 2024–2030.

Introduction And Strategic Context

The Global Non-Alcoholic Steatohepatitis ( NASH ) Treatment Market will witness a robust CAGR of 19.3 % , valued at $5.2 bi... Read More

Published Date: OCT-2025 | No Of Pages:175 | $ 4485

Catastrophic Antiphospholipid Syndrome Market By Treatment Modality (Plasma Exchange, Anticoagulation Therapy, Immunosuppressive Agents, Intravenous Immunoglobulins, Complement Inhibitors); By Diagnostic Approach (ELISA, Lupus Anticoagulant Testing, Beta-2 Glycoprotein I Testing, Next-Generation Sequencing); By End User (Hospitals & Critical Care Centers, Specialty Clinics & Immunology Centers, Academic & Research Institutions); By Geography, Segment Revenue Estimation, Forecast, 2024–2030

Introduction And Strategic Context

The Global Catastrophic Antiphospholipid Syndrome ( CAPS ) Market will witness a robust CAGR of 7.4% , valued at $654 million in 2024Read More

Published Date: OCT-2025 | No Of Pages:153 | $ 4485

Rheumatoid Arthritis Therapeutics Market By Drug Class (Conventional Synthetic DMARDs, Biologic DMARDs, Targeted Synthetic DMARDs, NSAIDs, Corticosteroids); By Route of Administration (Oral, Parenteral); By Distribution Channel (Hospital Pharmacies, Retail Pharmacies & Drug Stores, Online Pharmacies); By Geography, Segment Revenue Estimation, Forecast, 2024–2030

Introduction And Strategic Context

The Global Rheumatoid Arthritis Therapeutics Market will witness a robust CAGR of 6.8% , valued at $28.4 billion in 2024 , and is expected to appreciate and reach $42.1 billi... Read More

Published Date: OCT-2025 | No Of Pages:183 | $ 4485

Guillain-Barre Syndrome Market By Treatment Type (IVIG, Plasmapheresis, Steroid Therapy, Supportive Care); By Route of Administration (Intravenous, Oral, Subcutaneous); By End User (Hospitals, Neurology Clinics, ASCs, Rehabilitation Centers); By Geography, Segment Revenue Estimation, Forecast, 2024–2030.

Introduction And Strategic Context

The Global Guillain - Barré Syndrome ( GBS ) Market will witness a robust CAGR of ... Read More

Published Date: OCT-2025 | No Of Pages:186 | $ 4485

Huntington’s Disease Treatment Market By Treatment Type (Symptomatic Treatment, Disease-Modifying Therapies); By Route of Administration (Oral, Injectable, Others); By Distribution Channel (Hospital Pharmacies, Retail Pharmacies & Drug Stores, Specialty Pharmacies); By Geography, Segment Revenue Estimation, Forecast, 2024–2030.

Introduction And Strategic Context

The Global Huntington’s Disease Treatment Market will witness a robust CAGR of 21.1% , valued at $1.3 billion in 2024 , and is expected to app... Read More

Published Date: OCT-2025 | No Of Pages:171 | $ 4485

Endometriosis Treatment Market By Treatment Type (Hormonal Therapy, Pain Management, Surgery); By Route of Administration (Oral, Injectable, Others); By Distribution Channel (Hospital Pharmacies, Retail Pharmacies & Drug Stores, Online); By Geography, Segment Revenue Estimation, Forecast, 2024–2030

Introduction And Strategic Context

The Global Endometriosis Treatment Market will witness a robust CAGR of 7.6% , valued at USD 2.45 billion in 2024, expected to appreciate and reach USD 3.82 ... Read More

Published Date: OCT-2025 | No Of Pages:170 | $ 4485

Acromegaly Treatment Market By Drug Class (Somatostatin Analogs, Growth Hormone Receptor Antagonists, Dopamine Agonists, Emerging Therapies); By Route of Administration (Injectable, Oral); By End User (Hospitals & Specialty Clinics, Ambulatory Surgical Centers, Homecare & Tele-Endocrinology); By Geography, Segment Revenue Estimation, Forecast, 2024–2030.

Introduction And Strategic Context

The Global Acromegaly Treatment Market will witness a steady CAGR of 5.8% , valued at $2.1 billion in 2024 , expected to appreciate and reach $3.1 billion by 2030Read More

Published Date: OCT-2025 | No Of Pages:182 | $ 4485

Acute Repetitive Seizures Market By Product Type (Intranasal Rescue Therapies, Buccal and Sublingual Formulations, Injectable Rescue Medications); By Route of Administration (Nasal, Oral/Buccal, Intramuscular/Intravenous); By Distribution Channel (Hospital Pharmacies, Retail Pharmacies & Drug Stores, Online Pharmacies); By Geography, Segment Revenue Estimation, Forecast, 2024–2030.

Introduction And Strategic Context

The Global Acute Repetitive Seizures Market will witness a robust CAGR of 13.1% , valued at approximately $805 million in 2024 , expected to appreciate and reach around $1.67... Read More

Published Date: OCT-2025 | No Of Pages:181 | $ 4485

Postmenopausal Osteoporosis Treatment Market By Drug Class (Bisphosphonates, RANK Ligand Inhibitors, SERMs, Parathyroid Hormone Analogs, Calcitonin & Others); By Route of Administration (Oral, Injectable); By Distribution Channel (Hospital Pharmacies, Retail Pharmacies, Online Pharmacies); By Geography, Segment Revenue Estimation, Forecast, 2024–2030

Introduction And Strategic Context


The Global Postmenopausal Osteoporosis Treatment Market will witness a robust CAGR of 6.9%, valued at $14.63 billion in 2024, expected to appreciate and reach $22.42 ... Read More

Published Date: OCT-2025 | No Of Pages:183 | $ 4485

Pneumonia Therapeutics Market By Drug Class (Antibiotics, Antivirals, Antifungals, Monoclonal Antibodies, Adjunct Therapies); By Etiology (Bacterial, Viral, Fungal, Aspiration, Atypical); By Route of Administration (Oral, Intravenous, Inhalation); By End User (Hospitals, Specialty Clinics, Retail Pharmacies, Homecare Settings); By Geography, Segment Revenue Estimation, Forecast, 2024–2030.

Introduction And Strategic Context

The Global Pneumonia Therapeutics Market will witness a robust CAGR of 6.4 % , valued at $17.3 billion in 2024 , expected to appreciate and reach Read More

Published Date: OCT-2025 | No Of Pages:168 | $ 4485

Insomnia Therapeutics Market By Treatment Type (Prescription Medications [Non-benzodiazepine Hypnotics, Benzodiazepines, Melatonin Receptor Agonists, Orexin Receptor Antagonists], Over-the-Counter Sleep Aids, Digital and Behavioral Therapeutics); By Route of Administration (Oral, Transdermal, Others); By Distribution Channel (Retail Pharmacies, Hospital Pharmacies, Online Platforms); By Geography, Segment Revenue Estimation, Forecast, 2024–2030.

Introduction And Strategic Context

The Global Insomnia Therapeutics Market will witness a robust CAGR of 6.8% , valued at $4.9 billion in 2024 , expected to appreciate and reach $7.3 billion by 2030 ,... Read More

Published Date: OCT-2025 | No Of Pages:175 | $ 4485

Actinic Keratosis Treatment Market By Treatment Type (Topical Medications, Cryotherapy, Photodynamic Therapy, Laser Therapy, Others); By End User (Hospitals and Dermatology Clinics, Ambulatory Surgical Centers, Homecare Settings); By Geography, Segment Revenue Estimation, Forecast, 2024–2030.

Introduction And Strategic Context

The Global Actinic Keratosis Treatment Market will witness a robust CAGR of 6.8% , valued at $7.2 billion in 2024 , and is expected to appreciate an... Read More

Published Date: OCT-2025 | No Of Pages:176 | $ 4485

Paroxysmal Nocturnal Hemoglobinuria Market By Drug Type (C5 Inhibitors, C3 Inhibitors, Others); By Route of Administration (Intravenous, Subcutaneous, Oral); By Distribution Channel (Hospital Pharmacies, Specialty Pharmacies, Online Pharmacies); By End User (Hospitals, Specialty Clinics, Research Institutions); By Geography, Segment Revenue Estimation, Forecast, 2024–2030

Introduction And Strategic Context

The Global Paroxysmal Nocturnal Hemoglobinuria (PNH) Market will witness a robust CAGR of 9.7 % ,... Read More

Published Date: OCT-2025 | No Of Pages:166 | $ 4485

Hemophilia Treatment Market By Product Type (Plasma-Derived Coagulation Factor Concentrates, Recombinant Coagulation Factors, Non-Factor Replacement Therapies, Gene Therapy); By Disease Type (Hemophilia A, Hemophilia B, Others); By Treatment Approach (On-Demand Therapy, Prophylactic Therapy, Immune Tolerance Induction Therapy); By End User (Hospitals & Hemophilia Treatment Centers, Home Care Settings, Specialty Pharmacies); By Geography, Segment Revenue Estimation, Forecast, 2024–2030

Introduction And Strategic Context

The Global Hemophilia Treatment Market will witness a robust CAGR of 8.78 % , valued at $10.45 billionRead More

Published Date: OCT-2025 | No Of Pages:160 | $ 4485

Dementia Treatment Market By Treatment Type (Cholinesterase Inhibitors, NMDA Receptor Antagonists, Monoclonal Antibodies, Combination Therapies, Others); By Route of Administration (Oral, Intravenous, Transdermal); By End User (Hospitals and Memory Clinics, Homecare Settings, Long-Term Care Facilities, Research Centers); By Geography, Segment Revenue Estimation, Forecast, 2024–2030.

Introduction And Strategic Context

The Global Dementia Treatment Market will witness a robust CAGR of 12.8% , valued at $10.45 billion in 2024 , expected to appreciat... Read More

Published Date: OCT-2025 | No Of Pages:165 | $ 4485

Anxiety Disorder Treatment Market By Drug Class (SSRIs, SNRIs, Benzodiazepines, Beta-Blockers, Atypical Antipsychotics); By Therapy Type (CBT, Digital Therapeutics, Exposure Therapy, MBSR); By Distribution Channel (Hospital Pharmacies, Online Pharmacies, Mental Health Clinics, Retail Pharmacies); By Geography, Segment Revenue Estimation, Forecast, 2024–2030.

Introduction And Strategic Context

The Global Anxiety Disorder Treatment Market will witness a robust CAGR of 7.8% , valued at $12.4 billion in 2024 , and is expected to appreciate and reach $19.6 billion by 2... Read More

Published Date: OCT-2025 | No Of Pages:172 | $ 4485

Myeloproliferative Disorder Treatment Market By Disorder Type (PV, ET, PMF); By Treatment (JAK Inhibitors, Chemotherapy, Stem Cell Transplantation); By Route of Administration (Oral, Injectable); By Distribution Channel (Hospital, Retail, Online Pharmacies); By Geography, Segment Revenue Estimation, Forecast, 2024–2030.

Introduction And Strategic Context

The Global Myeloproliferative Disorder Treatment Market is expected to witness a steady CAGR of 6.9% , valued at $5.4 billion in 2024 , and projected to reach $8.1 billion by... Read More

Published Date: OCT-2025 | No Of Pages:151 | $ 4485

Pancreatic Cancer Treatment Market By Therapy Type (Chemotherapy, Targeted Therapy, Immunotherapy, Radiotherapy, Others); By Disease Stage (Localized, Locally Advanced, Metastatic); By End User (Hospitals & Cancer Centers, Specialty Clinics, Research & Academic Institutes); By Geography, Segment Revenue Estimation, Forecast, 2024–2030.

Introduction And Strategic Context

The Global Pancreatic Cancer Treatment Market will witness a robust CAGR of 11.8% , valued at USD 6.4 billion in 2024 , expected to appreciate and r... Read More

Published Date: OCT-2025 | No Of Pages:158 | $ 4485

Anterior Uveitis Treatment Market By Treatment Type (Corticosteroids, Cycloplegics, Biologics, Immunosuppressants, NSAIDs); By Route of Administration (Topical, Oral, Parenteral, Implants); By End User (Hospitals, Specialty Clinics, ASCs, Research Institutes); By Geography, Segment Revenue Estimation, Forecast, 2024–2030.

Introduction And Strategic Context

The Global Anterior Uveitis Treatment Market will witness a robust CAGR of 6.9% , valued at $494.7 million in 2024 , expected to appreciate and reac... Read More

Published Date: OCT-2025 | No Of Pages:159 | $ 4485

Gastroesophageal Reflux Disease (GERD) Therapeutics Market Gastroesophageal Reflux Disease Therapeutics Market By Drug Class (PPIs, H2 Receptor Antagonists, Antacids, Prokinetics, Mucosal Protectants); By Route of Administration (Oral, Intravenous); By Distribution Channel (Hospital Pharmacies, Retail Pharmacies, Online); By Geography, Segment Revenue Estimation, Forecast, 2024–2030.

Introduction And Strategic Context

The Global Gastroesophageal Reflux Disease (GERD) Therapeutics Market is projected to grow at a robust CAGR of 5.7% , increasing from USD 7.... Read More

Published Date: OCT-2025 | No Of Pages:171 | $ 4485

Inflammatory Bowel Disease (IBD) Treatment Market By Drug Class (Biologics [TNF-alpha Inhibitors, Integrin Inhibitors, Interleukin Inhibitors], Small Molecules [JAK Inhibitors, S1P Receptor Modulators], 5-ASA Derivatives, Corticosteroids, Immunomodulators, Others); By Disease Type (Crohn’s Disease, Ulcerative Colitis); By Route of Administration (Oral, Injectable, Rectal); By Distribution Channel (Hospital Pharmacies, Retail Pharmacies & Drug Stores, Online Pharmacies); By Geography, Segment Revenue Estimation, Forecast, 2024–2030.

Introduction And Strategic Context

The Global Inflammatory Bowel Disease (IBD) Treatment Market will witness a robust CAGR of 6.9% , valued at $24.8 billion in 2024 ,... Read More

Published Date: OCT-2025 | No Of Pages:187 | $ 4485

Metastatic Lung Adenocarcinoma Treatment Market By Therapy Type (Targeted Therapy, Immunotherapy, Chemotherapy, Radiotherapy, Combination Therapy); By Biomarker Status (EGFR Mutation, ALK Rearrangement, KRAS Mutation, PD-L1 Expression, Wild-Type); By Route of Administration (Oral, Intravenous, Subcutaneous); By End User (Hospitals, Specialty Clinics, Academic and Research Institutes); By Geography, Segment Revenue Estimation, Forecast, 2024–2030.

Introduction And Strategic Context

The Global Metastatic Lung Adenocarcinoma Treatment Market will witness a robust CAGR of 9.2% , valued at $12.4 billion in 2024 , and is expected to appreciate and r... Read More

Published Date: OCT-2025 | No Of Pages:193 | $ 4485

Neuroendocrine Tumor (NET) Treatment Market By Treatment Type (Somatostatin Analogs, Targeted Therapy, PRRT, Chemotherapy, Immunotherapy, Surgery); By Indication (GI NETs, Pancreatic NETs, Lung NETs, Others); By End User (Hospitals, Cancer Specialty Centers, Ambulatory Surgical Centers, Academic Research Institutes); By Geography, Segment Revenue Estimation, Forecast, 2024–2030.

Introduction And Strategic Context

The Global Neuroendocrine Tumor (NET) Treatment Market will witness a robust CAGR of 8.7% , value... Read More

Published Date: OCT-2025 | No Of Pages:160 | $ 4485

Transthyretin Amyloidosis Treatment Market By Drug Type (RNA Interference, Antisense Oligonucleotides, TTR Stabilizers, Supportive Therapies); By Route of Administration (Intravenous, Oral, Others); By End User (Hospitals & Specialty Clinics, Outpatient & Home Care, Research Centers); By Geography, Segment Revenue Estimation, Forecast, 2024–2030.

Introduction And Strategic Context

The Global Transthyretin Amyloidosis Treatment Market will witness a robust CAGR of 13.8% , valued at USD 2.1 billion in 2024, expe... Read More

Published Date: OCT-2025 | No Of Pages:168 | $ 4485

Infectious Disease Therapeutics Market By Product Type (Antiviral Drugs, Antibacterial Drugs, Antifungal and Antiparasitic Drugs, Monoclonal Antibodies and Immunotherapies); By Indication (HIV/AIDS, Hepatitis, Influenza, Tuberculosis, Malaria, Others); By Route of Administration (Oral, Parenteral, Topical); By Distribution Channel (Hospital Pharmacies, Retail Pharmacies, Online); By Geography, Segment Revenue Estimation, Forecast, 2024–2030.

Introduction And Strategic Context

The Global Infectious Disease Therapeutics Market will witness a robust CAGR of 7.4% , valued at approximately $145.6 billion in 2024 , and is expected to appreciate and reach Read More

Published Date: OCT-2025 | No Of Pages:156 | $ 4485

Sepsis Therapeutics Market By Drug Class (Antibiotics & Antimicrobials, Immunomodulators & Biologics, Adjuvant Therapies); By Pathogen Type (Gram-Negative Bacteria, Gram-Positive Bacteria, Fungal Infections); By Route of Administration (Intravenous, Oral); By End User (Hospitals & ICUs, Specialty Clinics & Research Institutions, Military & EMS); By Geography, Segment Revenue Estimation, Forecast, 2024–2030.

Introduction And Strategic Context

The Global Sepsis Therapeutics Market will witness a robust CAGR of 8.4% , valued at $5.1 billion in 2024 , expected to appreciate and reach $8.3 billion by ... Read More

Published Date: OCT-2025 | No Of Pages:194 | $ 4485

Polycystic Ovarian Syndrome (PCOS) Treatment Market By Drug Class (Hormonal Contraceptives, Insulin Sensitizers, Anti-Androgens, Fertility Agents, Others); By Route of Administration (Oral, Parenteral, Topical); By Distribution Channel (Hospital Pharmacies, Retail Pharmacies & Drug Stores, Online Pharmacies); By Geography, Segment Revenue Estimation, Forecast, 2024–2030.

Introduction And Strategic Context

The Global Polycystic Ovarian Syndrome ( PCOS ) Treatment Market will witness a robust CAGR of 6.8% , valued at approximately $5.2 billionRead More

Published Date: OCT-2025 | No Of Pages:194 | $ 4485

Alopecia Treatment Market By Product Type (Pharmaceuticals, Procedural Treatments, Cosmeceuticals & OTC Products); By Gender (Male, Female); By Distribution Channel (Dermatology Clinics & Hospitals, Aesthetic Clinics, Retail Pharmacies, Online Platforms); By Geography, Segment Revenue Estimation, Forecast, 2024–2030.

Introduction And Strategic Context

The Global Alopecia Treatment Market will witness a robust CAGR of 6.8% , valued at $10.4 billion in 2024, expected to appreciate and reach $15.4 billionRead More

Published Date: OCT-2025 | No Of Pages:161 | $ 4485

Celiac Disease Treatment Market By Drug Class (Enzyme Therapies, Tight Junction Modulators, Immune Modulators, Medical Foods & Supplements); By Route of Administration (Oral, Parenteral); By Distribution Channel (Hospital Pharmacies, Retail Pharmacies & Drug Stores, Online Pharmacies); By Geography, Segment Revenue Estimation, Forecast, 2024–2030.

Introduction And Strategic Context

The Global Celiac Disease Treatment Market will witness a robust CAGR of 8.5% , valued at USD 1.35 billion in 2024 , expected to appreciate and reach USD 2.2... Read More

Published Date: OCT-2025 | No Of Pages:155 | $ 4485

Post-Traumatic Stress Disorder Treatment Market By Treatment Type (Pharmacological Therapy, Non-Pharmacological Therapy, Combination Therapy); By Therapeutic Class (SSRIs, Antipsychotics, Beta-Blockers, Benzodiazepines, Others); By End User (Hospitals & Clinics, Mental Health Institutions, Military & Veterans Affairs Facilities, Digital Therapy Platforms); By Geography, Segment Revenue Estimation, Forecast, 2024–2030.

Introduction And Strategic Context

The Global Post-Traumatic Stress Disorder ( PTSD ) Treatment Market will witness a robust CAGR of 6.9% , valued at $8.4 billion in 2024 , and is exp... Read More

Published Date: OCT-2025 | No Of Pages:191 | $ 4485

Prostate Cancer Therapeutics Market By Therapy Type (Hormonal Therapy, Chemotherapy, Targeted Therapy, Immunotherapy, Radiopharmaceuticals); By Stage (Localized, Advanced/Metastatic, Castration-Resistant); By Distribution Channel (Hospital Pharmacies, Retail Pharmacies, Online Pharmacies); By Geography, Segment Revenue Estimation, Forecast, 2024–2030

Introduction And Strategic Context

The Global Prostate Cancer Therapeutics Market will witness a robust CAGR of 9.8 % , valued at $17.8 billion in 2024 , and is expected to appreciate... Read More

Published Date: OCT-2025 | No Of Pages:173 | $ 4485

Ulcerative Colitis Treatment Market By Drug Class (Aminosalicylates, Corticosteroids, Immunomodulators, Biologics, JAK Inhibitors, Others); By Disease Type (Mild, Moderate, Severe); By Route of Administration (Oral, Injectable, Rectal); By Geography, Segment Revenue Estimation, Forecast, 2024–2030

Introduction And Strategic Context

The Global Ulcerative Colitis Treatment Market is projected to witness a robust CAGR of 6.3% , valued at $7.9 billion in 2024 , and is expected to appreciate and reach $11.4 ... Read More

Published Date: OCT-2025 | No Of Pages:166 | $ 4485

Peptide Therapeutics Market By Type (Innovative Peptides, Generic Peptides); By Route of Administration (Parenteral, Oral, Others); By Application (Metabolic Disorders, Cancer, Cardiovascular Diseases, Infectious Diseases, Gastrointestinal Disorders, Others); By Geography, Segment Revenue Estimation, Forecast, 2024–2030

Introduction And Strategic Context

The Global Peptide Therapeutics Market will witness a robust CAGR of 7.8% , valued at $ 32.2 billion in 2024 , expected to appreciate and reach Read More

Published Date: OCT-2025 | No Of Pages:153 | $ 4485

Dry Eye Syndrome Treatment Market By Product Type (Artificial Tears, Anti-Inflammatory Drugs, Secretagogues, Autologous Serum Eye Drops, Punctal Plugs, Devices); By Disease Type (Evaporative, Aqueous Deficient, Mixed); By Distribution Channel (Hospital Pharmacies, Retail Pharmacies, Online); By Geography, Segment Revenue Estimation, Forecast, 2024–2030

Introduction And Strategic Context

The Global Dry Eye Syndrome Treatment Market will witness a robust CAGR of 8.4 % , valued at $ 7.5 billion in 2024 , and is ex... Read More

Published Date: OCT-2025 | No Of Pages:192 | $ 4485

Non-Small Cell Lung Cancer Therapeutics Market By Therapy Type (Targeted Therapy, Immunotherapy, Chemotherapy, Radiotherapy & Others); By Route of Administration (Oral, Intravenous, Others); By Distribution Channel (Hospital Pharmacies, Retail & Specialty Pharmacies); By Geography, Segment Revenue Estimation, Forecast, 2024–2030

Introduction And Strategic Context

The Global Non-Small Cell Lung Cancer Therapeutics Market will witness a robust CAGR of 9.4% , valued at $23.8 billion in 2024 , expected to appreciate and reach $40.8 billio... Read More

Published Date: OCT-2025 | No Of Pages:185 | $ 4485

Acute Myeloid Leukemia Treatment Market By Treatment Type (Chemotherapy, Targeted Therapy, Immunotherapy, Stem Cell Transplantation, Others); By Route of Administration (Oral, Injectable); By End User (Hospitals, Specialty Cancer Clinics, Academic & Research Institutions); By Geography, Segment Revenue Estimation, Forecast, 2024–2030.

Introduction And Strategic Context

The Global Acute Myeloid Leukemia Treatment Market will witness a strong CAGR of 11.2 %, valued at $ 5.3Read More

Published Date: OCT-2025 | No Of Pages:177 | $ 4485

Microbiome Therapeutics Market By Product Type (Live Biotherapeutic Products, Prebiotics & Postbiotics, Fecal Microbiota Transplantation); By Application (Gastrointestinal Disorders, Oncology, Metabolic Diseases, Neurological Disorders, Autoimmune Conditions); By Route of Administration (Oral, Rectal, Enteric-Coated, Others); By End User (Hospitals, Academic Institutions, Biotech Companies, CROs); By Geography, Segment Revenue Estimation, Forecast, 2024–2030.

Introduction And Strategic Context

The Global Microbiome Therapeutics Market will witness a robust CAGR of 31.8% , valued at $1.67 billion in 2024 , and is expected to appreciate and reach $10.83 billion by 20... Read More

Published Date: OCT-2025 | No Of Pages:186 | $ 4485

Duodenal Ulcer Treatment Market By Drug Class (Proton Pump Inhibitors, H2 Receptor Antagonists, Antibiotics, Protective Agents); By Route of Administration (Oral, Parenteral); By End User (Hospitals, Retail Pharmacies & Drug Stores, Online Pharmacies); By Geography, Segment Revenue Estimation, Forecast, 2024–2030

Introduction And Strategic Context

The Global Duodenal Ulcer Treatment Market will witness a robust CAGR of 7.2 % valued at USD 4.3 billion in 2024 , expected to appreciate and reach USD 6.1 b... Read More

Published Date: OCT-2025 | No Of Pages:162 | $ 4485

Cerebral Infarction Treatment Market By Treatment Type (Pharmacological Interventions [Thrombolytics, Antiplatelet Agents, Anticoagulants, Neuroprotective Agents], Surgical Procedures [Mechanical Thrombectomy, Carotid Endarterectomy, Decompressive Hemicraniectomy], Supportive and Adjunctive Care); By Mode of Administration (Intravenous, Oral, Intra-Arterial); By End User (Hospitals and Stroke Centers, Ambulatory Surgical Centers, Specialty Neurology Clinics, Rehabilitation Facilities); By Geography, Segment Revenue Estimation, Forecast, 2024–2030.

Introduction And Strategic Context

The Global Cerebral Infarction Treatment Market will witness a robust CAGR of 9.35 % , valued at approximately USD 9.4 billion in 2024 , expected to... Read More

Published Date: OCT-2025 | No Of Pages:177 | $ 4485

Acinetobacter Pneumonia Therapeutics Market By Drug Class (β-lactams, Polymyxins, Carbapenems, Sulbactam Combinations, Novel Agents); By Route of Administration (Intravenous, Oral, Inhalation); By End User (Hospitals, ICUs, ASCs, Military Facilities); By Geography, Segment Revenue Estimation, Forecast, 2024–2030.

Introduction And Strategic Context

The Global Acinetobacter Pneumonia Therapeutics Market will witness a promising CAGR of 7.6% , valued at $1.12 billion in 2024 , and is projected to... Read More

Published Date: OCT-2025 | No Of Pages:189 | $ 4485

Spinal Muscular Atrophy (SMA) Treatment Market By Treatment Type (Gene Therapy, Antisense Oligonucleotides, Small Molecule Drugs, Supportive Therapy); By Disease Type (Type I, Type II, Type III, Type IV); By Route of Administration (Intrathecal, Intravenous, Oral); By End User (Hospitals & Clinics, Homecare Settings, Academic & Research Institutes); By Geography, Segment Revenue Estimation, Forecast, 2024–2030.

Introduction And Strategic Context

The Global Spinal Muscular Atrophy ( SMA ) Treatment Market will witness a robust CAGR of 13.2 %, valued at $2.14 bill... Read More

Published Date: OCT-2025 | No Of Pages:154 | $ 4485

Uveitis Treatment Market By Drug Class (Corticosteroids, Immunosuppressive Agents, Biologics, Cycloplegics, Antimicrobials); By Disease Type (Anterior, Intermediate, Posterior, Panuveitis); By Route of Administration (Topical, Oral, Injectable, Implants); By Distribution Channel (Hospital Pharmacies, Retail Pharmacies, Online Pharmacies); By Geography, Segment Revenue Estimation, Forecast, 2024–2030.

Introduction And Strategic Context

The Global Uveitis Treatment Market will witness a robust CAGR of 6.8% , valued at $812.4 million in 2024 , expected to appreciate and reach $1.21 billion by 2030 , ... Read More

Published Date: OCT-2025 | No Of Pages:190 | $ 4485

Rosacea Treatment Market By Treatment Type (Topical Medications, Oral Antibiotics, Laser & Light Therapies, Biologics & Others, Cosmeceuticals & OTC); By Route of Administration (Topical, Oral, Injectable); By Distribution Channel (Hospital Pharmacies, Retail Pharmacies, Online Pharmacies, Aesthetic Clinics); By Geography, Segment Revenue Estimation, Forecast, 2024–2030

Introduction And Strategic Context

The Global Rosacea Treatment Market will witness a robust CAGR of 5.6 % , valued at $ 2.36 billion in 2024 , and i... Read More

Published Date: OCT-2025 | No Of Pages:155 | $ 4485

Stroke Management Market By Product Type (Diagnostics, Therapeutic Devices, Medications, Rehabilitation Solutions); By Application (Ischemic Stroke, Hemorrhagic Stroke, Transient Ischemic Attack); By End User (Hospitals & Stroke Centers, ASCs, Rehabilitation Facilities, Homecare); By Geography, Segment Revenue Estimation, Forecast, 2024–2030

Introduction And Strategic Context

The Global Stroke Management Market will witness a robust CAGR of 6.4% , valued at USD 31.5 billion in 2024 , expected to appreciate and reach USD 48.43Read More

Published Date: OCT-2025 | No Of Pages:156 | $ 4485

Stomach Cancer Treatment Market By Treatment Type (Chemotherapy, Targeted Therapy, Immunotherapy, Radiation Therapy, Surgery); By Cancer Type (Adenocarcinoma, Gastrointestinal Stromal Tumor, Lymphoma, Carcinoid Tumors); By End User (Hospitals, Specialty Cancer Clinics, Academic Research Institutes); By Geography, Segment Revenue Estimation, Forecast, 2024–2030

Introduction And Strategic Context

The Global Stomach Cancer Treatment Market will witness a robust CAGR of 7.2% , valued at USD 6.8 billion in 2024 , and is expected to appreciate and reach USD 10.4 billion b... Read More

Published Date: OCT-2025 | No Of Pages:189 | $ 4485

Prediabetes Market By Product Type (Diagnostic Solutions, Pharmacologic Treatments, Digital Therapeutics & Lifestyle Programs, Nutraceuticals); By Application (Screening & Risk Stratification, Disease Management & Prevention, Patient Engagement & Adherence Support); By End User (Hospitals & Specialty Clinics, Primary Care Settings, Homecare & Self-Testing, Employer & Community Health Programs); By Geography, Segment Revenue Estimation, Forecast, 2024–2030.

INTRODUCTION AND STRATEGIC CONTEXT

The Global Prediabetes Market will witness a robust CAGR of 8.6%, valued at $140.2 billion in 2024, expected to appreciate and reach $229.7 billion by 2030, confirms Strategic Market Research.

&nbs... Read More

Published Date: OCT-2025 | No Of Pages:173 | $ 4485

Peanut Allergy Treatment Market By Treatment Type (Immunotherapy [Oral, Epicutaneous, Sublingual], Biologic Therapy [Anti-IgE, Anti-IL Agents], Emergency Medication, Adjunct Therapy); By Route of Administration (Oral, Epicutaneous, Injectable, Sublingual); By Age Group (Pediatric, Adolescents, Adults); By Geography, Segment Revenue Estimation, Forecast, 2024–2030.

Introduction And Strategic Context

The Global Peanut Allergy Treatment Market will witness a robust CAGR of 10.7% , valued at USD 680 million in 2024 , expected to appreciate and reach USD 1.25 billion by 2030... Read More

Published Date: OCT-2025 | No Of Pages:180 | $ 4485

Onychomycosis Treatment Market By Treatment Type (Topical, Oral, Laser, Combination); By Infection Type (Distal Subungual, White Superficial, Proximal Subungual, Candidal, Total Dystrophic); By Drug Type (Prescription, OTC, Natural Remedies); By Distribution Channel (Hospital Pharmacies, Retail Pharmacies, Online); By Geography, Segment Revenue Estimation, Forecast, 2024–2030.

Introduction And Strategic Context

The Global Onychomycosis Treatment Market will witness a robust CAGR of 7.8% , valued at $ 3.5 billion in 2024 , and is expected to appreciate and r... Read More

Published Date: OCT-2025 | No Of Pages:200 | $ 4485

Myasthenia Gravis Treatment Market By Treatment Type (Medication-Based Therapy, Monoclonal Antibodies, Plasma-Based Therapies, Surgical Intervention); By Route of Administration (Oral, Intravenous, Subcutaneous); By Distribution Channel (Hospital Pharmacies, Retail Pharmacies, Specialty Clinics & Infusion Centers, Online); By Geography, Segment Revenue Estimation, Forecast, 2024–2030

Introduction And Strategic Context

The Global Myasthenia Gravis Treatment Market will witness a robust CAGR of 7.1% , valued at $1.46 billion in 2024 , and is expected to appreciate and reach $2.35 billion by ... Read More

Published Date: OCT-2025 | No Of Pages:185 | $ 4485

Cellular Rejuvenation Therapeutics Market By Therapy Type (Gene Therapy & Epigenetic Reprogramming, Senolytic Therapies, Stem Cell-Based Therapies, Exosome and Extracellular Vesicle Therapies); By Application (Neurodegenerative Diseases, Ophthalmology, Dermatology & Aesthetics, Musculoskeletal Disorders, Cardiovascular and Metabolic Disorders); By Delivery Mechanism (Systemic, Localized, Genetic Delivery); By Geography, Segment Revenue Estimation, Forecast, 2024–2030

1. Introduction and Strategic Context

The Global Cellular Rejuvenation Therapeutics Market is poised for a transformative run, advancing at a CAGR of 19.6%, with a valuation of USD 1.34 billion in 2024, expected to re... Read More

Published Date: OCT-2025 | No Of Pages:150 | $ 4485

Organoid-Based Therapeutic Implants Market By Organoid Type (Liver Organoids, Retinal Organoids, Intestinal Organoids, Pancreatic Organoids); By Application (Ophthalmology, Hepatology, Gastroenterology, Endocrinology, Nephrology); By End User (Academic Medical Centers, Tertiary Hospitals, Specialty Clinics); By Geography, Segment Revenue Estimation, Forecast, 2024–2030

1. Introduction and Strategic Context

The Global Organoid-Based Therapeutic Implants Market is on track to grow at a CAGR of 27.8%, reaching USD 1.36 billion by 2030, up from an estimated USD 312.5 million in ... Read More

Published Date: Oct-2025 | No Of Pages:191 | $ 4485

Psoriasis Treatment Market By Drug Class (Biologics, Topical Therapies, Systemic Non-biologics, Biosimilars); By Route of Administration (Injectable, Oral, Topical); By Distribution Channel (Hospital Pharmacies, Retail Pharmacies & Drug Stores, Online Pharmacies); By Geography, Segment Revenue Estimation, Forecast, 2024–2030.

Introduction And Strategic Context

The Global Psoriasis Treatment Market will witness a robust CAGR of 8.1% , valued at USD 32.5 billion in 2024 , expected to appreciate and reach Read More

Published Date: OCT-2025 | No Of Pages:175 | $ 4485

Androgenetic Alopecia Market By Product Type (Oral Pharmaceuticals, Topical Solutions, Hair Transplant Devices & Procedures, Regenerative Therapies, Cosmetic Camouflaging Products); By Gender (Male, Female); By Distribution Channel (Hospital Pharmacies, Retail Pharmacies & Drug Stores, Online Channels); By Geography, Segment Revenue Estimation, Forecast, 2024–2030.

Introduction And Strategic Context

The Global Androgenetic Alopecia Market will witness a robust CAGR of 6.8% , valued at approximately $8.4 billion in 2024 , expecte... Read More

Published Date: OCT-2025 | No Of Pages:150 | $ 4485

Invasive Ductal Carcinoma Treatment Market By Treatment Type (Surgery, Chemotherapy, Radiation Therapy, Hormonal Therapy, Targeted Therapy, Immunotherapy); By Therapy Modality (Monotherapy, Combination Therapy, Adjuvant Therapy, Neoadjuvant Therapy); By End User (Hospitals, Cancer Specialty Clinics, ASCs, Academic and Research Institutions); By Geography, Segment Revenue Estimation, Forecast, 2024–2030.

Introduction And Strategic Context

The Global Invasive Ductal Carcinoma Treatment Market will witness a robust CAGR of 7.9% , valued at $17.6 billion in 2024 , expected to appreciate and reach $27.8 billion by... Read More

Published Date: OCT-2025 | No Of Pages:171 | $ 4485

Duchenne Muscular Dystrophy Treatment Market By Therapy Type (Corticosteroids, Exon-Skipping Therapies, Gene Therapy, Others); By Route of Administration (Oral, Intravenous, Subcutaneous); By Distribution Channel (Hospital Pharmacies, Retail Pharmacies, Specialty Clinics); By Geography, Segment Revenue Estimation, Forecast, 2024–2030.

Introduction And Strategic Context

The Global Duchenne Muscular Dystrophy (DMD) Treatment Market will witness a robust CAGR of 13.8% , valued at $Read More

Published Date: OCT-2025 | No Of Pages:167 | $ 4485

Systemic Lupus Erythematosus Treatment Market By Drug Class (Antimalarials, NSAIDs, Corticosteroids, Immunosuppressants, Biologics and Targeted Therapies); By Route of Administration (Oral, Parenteral); By Distribution Channel (Hospital Pharmacies, Retail Pharmacies & Drug Stores, Online Pharmacies); By Geography, Segment Revenue Estimation, Forecast, 2024–2030.

Introduction And Strategic Context

The Global Systemic Lupus Erythematosus Treatment Market will witness a robust CAGR of 7.9% , valued at $3.65 billion in 2024, expected to appreciate and reach Read More

Published Date: OCT-2025 | No Of Pages:171 | $ 4485

Chemotherapy-Induced Neutropenia Treatment Market By Product Type (G-CSFs, Biosimilars, Antibiotics & Antifungals, Others); By Route of Administration (Subcutaneous, Intravenous, Oral); By End User (Hospitals, Oncology Clinics, Homecare Settings, Retail Pharmacies); By Geography, Segment Revenue Estimation, Forecast, 2024–2030.

Introduction And Strategic Context

The Global Chemotherapy-Induced Neutropenia (CIN) Treatment Market will witness a robust CAGR of 6.8%, valued at $12.3 billion in 2024 , and is expe... Read More

Published Date: OCT-2025 | No Of Pages:185 | $ 4485

Epithelioma Treatment Market By Treatment Type (Surgical Intervention, Radiation Therapy, Chemotherapy, Immunotherapy & Targeted Therapy, Photodynamic Therapy); By Cancer Type (Basal Cell Carcinoma, Squamous Cell Carcinoma, Transitional Cell Carcinoma, Other Rare Epitheliomas); By Route of Administration (Oral, Intravenous, Topical, Intralesional); By End User (Hospitals & Specialty Cancer Centers, Ambulatory Surgical Centers, Dermatology Clinics, Research Institutes); By Geography, Segment Revenue Estimation, Forecast, 2024–2030.

Introduction And Strategic Context

The Global Epithelioma Treatment Market will witness a robust CAGR of 9.1% , valued at USD 2.1 billion in 2024, ex... Read More

Published Date: OCT-2025 | No Of Pages:164 | $ 4485

Opioid Use Disorder Treatment Market By Product Type (Medication-Assisted Treatment, Behavioral Therapy & Counseling, Digital Therapeutics); By Route of Administration (Oral, Sublingual, Injectable); By Treatment Setting (Outpatient, Residential/Inpatient, Telehealth); By Distribution Channel (Specialized Opioid Treatment Programs, Hospitals & Clinics, Retail Pharmacies, Online Pharmacies & Digital Platforms); By Geography, Segment Revenue Estimation, Forecast, 2024–2030.

Introduction And Strategic Context

The Global Opioid Use DisorderTreatment Market will witness a robust CAGR of 7.3% , valued at $5.4 billion in 2024, expected to app... Read More

Published Date: OCT-2025 | No Of Pages:175 | $ 4485

Pruritus Therapeutics Market By Drug Class (Antihistamines, Corticosteroids, Calcineurin Inhibitors, Opioid Receptor Modulators, Biologic Therapies); By Route of Administration (Topical, Oral, Injectable); By Disease Type (Atopic Dermatitis, Chronic Kidney Disease–Associated Pruritus, Psoriasis, Cholestatic Pruritus, Others); By Geography, Segment Revenue Estimation, Forecast, 2024–2030

Introduction And Strategic Context

The Global Pruritus Therapeutics Market will witness a robust CAGR of 5.8% , valued at $7.4 billion in 2024 , expected to appreciate and reach $10.4 billion by 2030 ... Read More

Published Date: OCT-2025 | No Of Pages:169 | $ 4485